Document Detail

Clinical comparison of two hyaluronic acid-derived fillers in the treatment of nasolabial folds: Mesoglow(®) and IAL System(®).
MedLine Citation:
PMID:  22515587     Owner:  NLM     Status:  In-Data-Review    
Hyaluronic acid (HA) dermal fillers are widely used to reduce the appearance of aging. However, comparative research on the efficacy and safety of products of similar composition is limited. We compared outcomes achieved with two non-cross-linked HA fillers of almost identical composition, Mesoglow(®) and IAL System(®) . Forty subjects with visible nasolabial folds (NLFs) were enrolled in a randomized study. Wrinkle severity was rated using the 5-point Wrinkle Severity Rating Scale (WSRS). Each subject was injected with Mesoglow(®) in one NLF and IAL System(®) in the other. An optimal cosmetic result was established at two weeks after a second treatment. Participants were then reassessed at 2, 6, and 12 weeks, respectively, post-optimal cosmetic result using the WSRS. The degree of improvement was also assessed by subjects and investigators using the Global Aesthetic Improvement Scale (GAIS). At baseline, the mean WSRS score was 3.20 ± 0.41. At the optimal cosmetic result, 98% of subjects showed a 1- or 2-point change in WSRS score with either treatment. All subsequent WSRS scores were significantly improved over baseline for both treatments. There was no significant difference between treatments or improvement in WSRS score at any point in time. Investigator GAIS scores at weeks 4 and 6 were slightly but not significantly higher for Mesoglow(®) -treated skin. There was no significant difference in the frequency of local adverse responses. No serious systemic adverse events occurred. This study indicates that Mesoglow(®) and IAL System(®) are equally effective in achieving short-term correction of NLFs, but the longevity of their effects is limited.
Ji Young Ahn; See Hyun Lee; Kui Young Park; Chang Kwun Hong; Hae Jun Song; Mi Youn Park; Yu Sung Choi; Seong Jun Seo
Related Documents :
25043517 - Testing devices for the prevention and treatment of stroke and its complications.
22428137 - Cosmetic benefits of astaxanthin on humans subjects.
9052907 - Subcutaneous versus intravenous low-dose il-2 therapy after autologous transplantation:...
15787627 - Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients...
21898717 - Does the presence of accompanying symptom clusters differentiate the comparative effect...
22648627 - Consumption of a grape extract supplement containing resveratrol decreases oxidized ldl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  51     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  601-8     Citation Subset:  IM    
Copyright Information:
© 2012 The International Society of Dermatology.
Department of Dermatology, National Medical Center, Seoul, South Korea Department of Dermatology, Chung-Ang University Medical Center, Seoul, South Korea Department of Dermatology, College of Medicine, Korea University, Seoul, South Korea Department of Dermatology, Ulsan University Hospital, Ulsan, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence survey of dermatological conditions in mountainous north India.
Next Document:  Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen g...